CoChat

The concept of entero‐colonic encephalopathy, autism and opioid receptor ligands

Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., O'Leary, J. J., Murch, S. H. · 2002 · Alimentary Pharmacology & Therapeutics
Cited by 100

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

There is growing awareness that primary gastrointestinal pathology may play an important role in the inception and clinical expression of some childhood developmental disorders, including autism. In addition to frequent gastrointestinal symptoms, children with autism often manifest complex biochemical and immunological abnormalities. The gut–brain axis is central to certain encephalopathies of extra‐cranial origin, hepatic encephalopathy being the best characterized. Commonalities in the clinical characteristics of hepatic encephalopathy and a form of autism associated with developmental regression in an apparently previously normal child, accompanied by immune‐mediated gastrointestinal pathology, have led to the proposal that there may be analogous mechanisms of toxic encephalopathy in patients with liver failure and some children with autism. Aberrations in opioid biochemistry are common to these two conditions, and there is evidence that opioid peptides may mediate certain aspects of the respective syndromes. The generation of plausible and testable hypotheses in this area may help to identify new treatment options in encephalopathies of extra‐cranial origin. Therapeutic targets for this autistic phenotype may include: modification of diet and entero‐colonic microbial milieu in order to reduce toxin substrates, improve nutritional status and modify mucosal immunity; anti‐inflammatory/immunomodulatory therapy; and specific treatment of dysmotility, focusing, for example, on the pharmacology of local opioid activity in the gut.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2002.01206.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 14 references

Cited by

See all 100

Metadata

Authors
Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., O'Leary, J. J., & Murch, S. H.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2002-04
Volume
16
Issue
4
Pages
663-674
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2088180052
Cited by
100
References
14
FWCI
4.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The concept of entero‐colonic encephalopathy, autism and opioid receptor ligands. https://app.cochat.ai/papers/10.1046/j.1365-2036.2002.01206.x
The paper
Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., O'Leary, J. J., & Murch, S. H. (2002). The concept of entero‐colonic encephalopathy, autism and opioid receptor ligands. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01206.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.